It is not known whether COX-2 expression is a prognostic factor, independently of other known prognostic factors, including tumor features and molecular characteristics, such as stage (tumor, node, metastasis), differentiation, age, sex and weight loss, and data on cancer treatment are limited in our meta-analysis. The gene discussed is PTGS2; the disease is neoplasm.